Novel organoid model in drug screening: Past, present, and future
Advances in the field of stem cells have led to the development of a technology called organoids. Organoids are cell cluster structures formed by the cultivation of stem cells in a three-dimensional environment in vitro, and they can simulate the living environment of cells in vivo. Organoids play a...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2021-06-01
|
Series: | Liver Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S254256842100026X |
id |
doaj-dfb33eed80874762bb589fbd1e41c92e |
---|---|
record_format |
Article |
spelling |
doaj-dfb33eed80874762bb589fbd1e41c92e2021-07-01T04:35:12ZengKeAi Communications Co., Ltd.Liver Research2542-56842021-06-01527278Novel organoid model in drug screening: Past, present, and futureXialin Nie0Zhixing Liang1Kun Li2Haoyuan Yu3Yuhan Huang4Linsen Ye5Yang Yang6Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China; Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China; Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China; Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaSchool of Foreign Languages, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China; Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Corresponding authors. Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China; Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Corresponding authors. Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.Advances in the field of stem cells have led to the development of a technology called organoids. Organoids are cell cluster structures formed by the cultivation of stem cells in a three-dimensional environment in vitro, and they can simulate the living environment of cells in vivo. Organoids play an important role in the screening of drugs for tumor therapy. Compared with traditional drug screening models, tumor organoid models derived from patient tumors have higher sensitivity, heterogeneity, and stability and can restore the real situation of tumors more effectively. Researchers have conducted a number of researches on the feasibility of using organoid technology in drug screening. By testing and comparing the effects of antitumor drugs in organoids and primary tumors, we can select the most appropriate treatment drugs for patients. In the past ten years, organoids from dozens of tissues and biological sample banks from several main organs have been established, and a large number of anticancer drugs have been screened out. This article summarizes the advantages and disadvantages of traditional drug screening models, discusses the development history of organoid technology, and reviews the research results on organoids from tumor drug screening. In addition, the combination of organoid technology and other modern biotechnologies is put forward to further promote the role of organoid technology in the medical field. Finally, this article reviews the history, progress, and prospect on organoids from the view of antitumor drug screening.http://www.sciencedirect.com/science/article/pii/S254256842100026XOrganoidDrug screeningPatient-derived cancer cell line (PDC) modelPatient-derived xenograft (PDX) modelPatient-derived organoid (PDO) model |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xialin Nie Zhixing Liang Kun Li Haoyuan Yu Yuhan Huang Linsen Ye Yang Yang |
spellingShingle |
Xialin Nie Zhixing Liang Kun Li Haoyuan Yu Yuhan Huang Linsen Ye Yang Yang Novel organoid model in drug screening: Past, present, and future Liver Research Organoid Drug screening Patient-derived cancer cell line (PDC) model Patient-derived xenograft (PDX) model Patient-derived organoid (PDO) model |
author_facet |
Xialin Nie Zhixing Liang Kun Li Haoyuan Yu Yuhan Huang Linsen Ye Yang Yang |
author_sort |
Xialin Nie |
title |
Novel organoid model in drug screening: Past, present, and future |
title_short |
Novel organoid model in drug screening: Past, present, and future |
title_full |
Novel organoid model in drug screening: Past, present, and future |
title_fullStr |
Novel organoid model in drug screening: Past, present, and future |
title_full_unstemmed |
Novel organoid model in drug screening: Past, present, and future |
title_sort |
novel organoid model in drug screening: past, present, and future |
publisher |
KeAi Communications Co., Ltd. |
series |
Liver Research |
issn |
2542-5684 |
publishDate |
2021-06-01 |
description |
Advances in the field of stem cells have led to the development of a technology called organoids. Organoids are cell cluster structures formed by the cultivation of stem cells in a three-dimensional environment in vitro, and they can simulate the living environment of cells in vivo. Organoids play an important role in the screening of drugs for tumor therapy. Compared with traditional drug screening models, tumor organoid models derived from patient tumors have higher sensitivity, heterogeneity, and stability and can restore the real situation of tumors more effectively. Researchers have conducted a number of researches on the feasibility of using organoid technology in drug screening. By testing and comparing the effects of antitumor drugs in organoids and primary tumors, we can select the most appropriate treatment drugs for patients. In the past ten years, organoids from dozens of tissues and biological sample banks from several main organs have been established, and a large number of anticancer drugs have been screened out. This article summarizes the advantages and disadvantages of traditional drug screening models, discusses the development history of organoid technology, and reviews the research results on organoids from tumor drug screening. In addition, the combination of organoid technology and other modern biotechnologies is put forward to further promote the role of organoid technology in the medical field. Finally, this article reviews the history, progress, and prospect on organoids from the view of antitumor drug screening. |
topic |
Organoid Drug screening Patient-derived cancer cell line (PDC) model Patient-derived xenograft (PDX) model Patient-derived organoid (PDO) model |
url |
http://www.sciencedirect.com/science/article/pii/S254256842100026X |
work_keys_str_mv |
AT xialinnie novelorganoidmodelindrugscreeningpastpresentandfuture AT zhixingliang novelorganoidmodelindrugscreeningpastpresentandfuture AT kunli novelorganoidmodelindrugscreeningpastpresentandfuture AT haoyuanyu novelorganoidmodelindrugscreeningpastpresentandfuture AT yuhanhuang novelorganoidmodelindrugscreeningpastpresentandfuture AT linsenye novelorganoidmodelindrugscreeningpastpresentandfuture AT yangyang novelorganoidmodelindrugscreeningpastpresentandfuture |
_version_ |
1721347336018329600 |